Open Access Articles


Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*




PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145 - 158

Kristin N. Taylor and Ramez N. Eskander*





Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86 - 105

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*





Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage

, 2018; 13(1): 18 - 39

So-Yeon Park, Ji-Young Kim, Youngsoo Jun and Jeong-Seok Nam*





Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 2018; 13: 1 - 4 (E-Pub Ahead of Print)

A. E. Shchekotikhin*, Georgy Y. Nadysev, Alexander S. Tikhomirov and Lyubov G. Dezhenkova





Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens

, 2017; 12(2): 136 - 147

Zsuzsanna Suba*





Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review

, 2017; 12(1): 55 - 72

Anuj K. Rathi, Riyaz Syed, Vijay Singh, Han-Seung Shin and Rahul V. Patel




Recent Patents on Proteasome Inhibitors of Natural Origin

, 2017; 12(1): 4 - 15

Daniela Correia da Silva, Paula B. Andrade, Vera Ribeiro, Patricia Valentao and David M. Pereira




Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)

, 2017; 12(1): 16 - 34

Peng Zhan, Xueshun Wang, Xinyong Liu and Takayoshi Suzuki





Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

, 2016; 11(2): 184 - 196

Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian Luo




Cabozantinib in Thyroid Cancer

, 2015; 10(3): 259 - 269

Poupak Fallahi, Silvia M. Ferrari, Flavia Di Bari, Gabriele Materazzi, Salvatore Benvenga, Paolo Miccoli and Alessandro Antonelli




Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women

, 2013; 8(2): 154 - 167

Zsuzsanna Suba






Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science